794 related articles for article (PubMed ID: 23736003)
1. Mesenchymal stem cells: a new trend for cell therapy.
Wei X; Yang X; Han ZP; Qu FF; Shao L; Shi YF
Acta Pharmacol Sin; 2013 Jun; 34(6):747-54. PubMed ID: 23736003
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells.
Zhang Y; Xu J; Liu S; Lim M; Zhao S; Cui K; Zhang K; Wang L; Ji Q; Han Z; Kong D; Li Z; Liu N
Theranostics; 2019; 9(23):6976-6990. PubMed ID: 31660081
[No Abstract] [Full Text] [Related]
3. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
Wang LT; Ting CH; Yen ML; Liu KJ; Sytwu HK; Wu KK; Yen BL
J Biomed Sci; 2016 Nov; 23(1):76. PubMed ID: 27809910
[TBL] [Abstract][Full Text] [Related]
4. MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research.
Zhang X; Kuang Q; Xu J; Lin Q; Chi H; Yu D
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785945
[TBL] [Abstract][Full Text] [Related]
5. Advancing Mesenchymal Stem Cell Therapy with CRISPR/Cas9 for Clinical Trial Studies.
Golchin A; Shams F; Karami F
Adv Exp Med Biol; 2020; 1247():89-100. PubMed ID: 31974923
[TBL] [Abstract][Full Text] [Related]
6. Are mesenchymal stromal cells immune cells?
Hoogduijn MJ
Arthritis Res Ther; 2015 Mar; 17(1):88. PubMed ID: 25880839
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
Kahmini FR; Shahgaldi S
Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of mesenchymal stem cells.
Abumaree M; Al Jumah M; Pace RA; Kalionis B
Stem Cell Rev Rep; 2012 Jun; 8(2):375-92. PubMed ID: 21892603
[TBL] [Abstract][Full Text] [Related]
9. Does the route matter? A preclinical review of mesenchymal stromal cell delivery to the kidney.
Kresse JC; Gregersen E; Atay JCL; Eijken M; Nørregaard R
APMIS; 2023 Dec; 131(12):687-697. PubMed ID: 37750005
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases.
Eljarrah A; Gergues M; Pobiarzyn PW; Sandiford OA; Rameshwar P
Adv Exp Med Biol; 2019; 1201():93-108. PubMed ID: 31898783
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
12. Challenges and advances in clinical applications of mesenchymal stromal cells.
Zhou T; Yuan Z; Weng J; Pei D; Du X; He C; Lai P
J Hematol Oncol; 2021 Feb; 14(1):24. PubMed ID: 33579329
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.
Holan V; Palacka K; Hermankova B
Cells; 2021 Mar; 10(3):. PubMed ID: 33799995
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells.
Chen BY; Wang X; Chen LW; Luo ZJ
Curr Drug Targets; 2012 Apr; 13(4):561-71. PubMed ID: 22443584
[TBL] [Abstract][Full Text] [Related]
15. A review on different methods to increase the efficiency of mesenchymal stem cell-based wound therapy.
Shojaei F; Rahmati S; Banitalebi Dehkordi M
Wound Repair Regen; 2019 Nov; 27(6):661-671. PubMed ID: 31298446
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Liau LL; Ruszymah BHI; Ng MH; Law JX
Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic applications of mesenchymal stem cells in the oral and maxillofacial tissues.
Al-Hamad KA; Shanab HG; Gaballah OM; Moawad AAR; Alayfan G; Alshebel A; Alqahtani AMA; Almaziad M
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):6006-6017. PubMed ID: 37458639
[TBL] [Abstract][Full Text] [Related]
18. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of heat-inactivated, secretome-deficient MSC and metabolically active MSC in sepsis and allogenic heart transplantation.
Weiss ARR; Lee O; Eggenhofer E; Geissler E; Korevaar SS; Soeder Y; Schlitt HJ; Geissler EK; Hoogduijn MJ; Dahlke MH
Stem Cells; 2020 Jun; 38(6):797-807. PubMed ID: 32101344
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell therapy following muscle trauma leads to improved muscular regeneration in both male and female rats.
von Roth P; Duda GN; Radojewski P; Preininger B; Perka C; Winkler T
Gend Med; 2012 Apr; 9(2):129-36. PubMed ID: 22361839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
